A Cross-Sectional Study of Atherosclerosis in Newly Diagnosed Patients with Ketosis-Prone Type 2 Diabetes

References

• Lebovitz HE, Banerji MA. Ketosis-prone diabetes (flatbush diabetes): an emerging worldwide clinically important entity. Curr Diab Rep. 2018;18(11):120. doi:10.1007/s11892-018-1075-4
   PubMed Web of Science ®Google Scholar
• Gupta RD, Ramachandran R, Gangadhara P, et al. Clinical characteristics, beta-cell dysfunction and treatment outcomes in patients with A − β + ketosis-prone diabetes (KPD): the first identified cohort amongst Asian Indians. J Diabetes Complications. 2017;31(9):1401–1407. doi:10.1016/j.jdiacomp.2017.06.008
   Web of Science ®Google Scholar
• Boyne MS. Arginine metabolism and A-β + ketosis-prone diabetes. J Nutr. 2018;148(2):170–171. doi:10.1093/jn/nxx066
   Web of Science ®Google Scholar
• Choukem SP, Sobngwi E, Boudou P, et al. β- and α-cell dysfunctions in Africans with ketosis-prone atypical diabetes during near-normoglycemic remission. Diabetes Care. 2013;36(1):118–123. doi:10.2337/dc12-0798
   Web of Science ®Google Scholar
• Winter WE, Maclaren NK, Riley WJ, Clarke DW, Kappy MS, Spillar RP. Maturity-onset diabetes of youth in black Americans. N Engl J Med. 1987;316(6):285–291. doi:10.1056/NEJM198702053160601
   PubMed Web of Science ®Google Scholar
• Lu H, Hu F, Zeng Y, et al. Ketosis onset type 2 diabetes had better Islet β -cell function and more serious insulin resistance. J Diabetes Res. 2014;2014:1–6. doi:10.1155/2014/510643
   Web of Science ®Google Scholar
• World Health Organization. Classification of diabetes mellitus. World Health Organization; 2019. Available from: https://apps.who.int/iris/handle/10665/325182. Accessed October 25, 2021.
   Google Scholar
• Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M. Prediabetes: a high-risk state for diabetes development. Lancet. 2012;379(9833):2279–2290. doi:10.1016/S0140-6736(12)60283-9
   PubMed Web of Science ®Google Scholar
• Li L, Yu H, Zhu J, et al. The combination of carotid and lower extremity ultrasonography increases the detection of atherosclerosis in type 2 diabetes patients. J Diabetes Complications. 2012;26(1):23–28. doi:10.1016/j.jdiacomp.2011.11.006
   Web of Science ®Google Scholar
• Li LX, Zhao CC, Ren Y, et al. Prevalence and clinical characteristics of carotid atherosclerosis in newly diagnosed patients with ketosis-onset diabetes: a cross-sectional study. Cardiovasc Diabetol. 2013;12(1):18. doi:10.1186/1475-2840-12-18
   Web of Science ®Google Scholar
• Li MF, Ren Y, Zhao CC, et al. Prevalence and clinical characteristics of lower limb atherosclerotic lesions in newly diagnosed patients with ketosis-onset diabetes: a cross-sectional study. DiabetolMetabSyndr. 2014;6:71. doi:10.1186/1758-5996-6-71
   Web of Science ®Google Scholar
• American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2020. Diabetes Care. 2020;43(Suppl 1):S14–S31. doi:10.2337/dc20-S002
   PubMed Web of Science ®Google Scholar
• Lu B, Yang Y, Song X, et al. An evaluation of the International Diabetes Federation definition of metabolic syndrome in Chinese patients older than 30 years and diagnosed with type 2 diabetes mellitus. Metabolism. 2006;55(8):1088–1096. doi:10.1016/j.metabol.2006.04.003
   Web of Science ®Google Scholar
• Yin X, Yang X, Zhang T, et al. Changes of body mass index and body shape in relation to risk of gastric cancer: a population-based case-control study. J Cancer. 2021;12(10):3089–3097. doi:10.7150/jca.56149
   Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612. doi:10.7326/0003-4819-150-9-200905050-00006
   PubMed Web of Science ®Google Scholar
• Fan H, Pan Q, Zhang P, Liu J, Xu Y, Yang X. Influence of islet function on typing and prognosis of new-onset diabetes after intensive insulin therapy. Med Sci Monit. 2013;19:787–793. doi:10.12659/MSM.889099
   PubMed Web of Science ®Google Scholar
• Touboul PJ, Hennerici MG, Meairs S, et al. Mannheim intima-media thickness consensus. Cerebrovasc Dis. 2004;18(4):346–349. doi:10.1159/000081812
   PubMed Web of Science ®Google Scholar
• Bembi V, Singh S, Singh P, Aneja GK, Arya TVS, Arora R. Prevalence of peripheral arterial disease in a cohort of diabetic patients. South Med J. 2006;99(6):564–569. doi:10.1097/01.smj.0000221624.68378.5d
   Web of Science ®Google Scholar
• Li TT, Wang AP, Lu JX, et al. Prevalence and clinical characteristics of non-alcoholic fatty liver disease in newly diagnosed patients with ketosis-onset diabetes. Diabetes Metab. 2018;44(5):437–443. doi:10.1016/j.diabet.2018.03.002
   Web of Science ®Google Scholar
• Ye S, Ran H, Zhang H, et al. Elevated serum triglycerides are associated with ketosis-prone type 2 diabetes in young individuals. Diabetes Metab Syndr Obes. 2021;14:497–504. doi:10.2147/DMSO.S296085
   PubMed Web of Science ®Google Scholar
• Blouin K, Boivin A, Tchernof A. Androgens and body fat distribution. J Steroid Biochem Mol Biol. 2008;108(3–5):272–280. doi:10.1016/j.jsbmb.2007.09.001
   PubMed Web of Science ®Google Scholar
• van Nas A, Guhathakurta D, Wang SS, et al. Elucidating the role of gonadal hormones in sexually dimorphic gene coexpression networks. Endocrinology. 2009;150(3):1235–1249. doi:10.1210/en.2008-0563
   PubMed Web of Science ®Google Scholar
• Zhang M, Li Y, Cui W, et al. The clinical and metabolic characteristics of young-onset ketosis-prone type 2 diabetes in China. Endocr Pract. 2015;21(12):1364–1371. doi:10.4158/EP15778.OR
   PubMed Web of Science ®Google Scholar
• Umpierrez GE, Smiley D, Gosmanov A, Thomason D. Ketosis-prone type 2 diabetes: effect of hyperglycemia on β-cell function and skeletal muscle insulin signaling. Endocr Pract. 2007;13(3):283–290. doi:10.4158/EP.13.3.283
   Google Scholar
• Haas AV, McDonnell ME. Pathogenesis of cardiovascular disease in diabetes. Endocrinol Metab Clin North Am. 2018;47(1):51–63. doi:10.1016/j.ecl.2017.10.010
   PubMed Web of Science ®Google Scholar
• Jain SK, McVie R, Jaramillo JJ, Chen Y. Hyperketonemia (acetoacetate) increases the oxidizability of LDL + VLDL in type-I diabetic patients. Free Radic Biol Med. 1998;24(1):175–181. doi:10.1016/s0891-5849(97)00213-x
   Web of Science ®Google Scholar